Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratumoral PTS for advanced lung cancer and intrapleural PTS for malignant pleural effusion
CTR20132352Phase 2Completed
- Sponsor
- Wu Yizhuang
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of para-toluenesulfonamide in bronchial carcinoma, malignant pleural effusion (MPE), sponsored by Wu Yizhuang. Started Jun 2014; status: completed.
02
Drugs
para-toluenesulfonamide
03
Conditions
bronchial carcinomamalignant pleural effusion (MPE)
Beyond the preview
Go deeper on CTR20132352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132352.